Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 57 results for "zydus cadila"

Zydus Cadila gets USFDA nod to market muscle relaxant in US
Money Control

Zydus Cadila gets USFDA nod to market muscle relaxant in US

"The company has received final approval from the US Food and Drug Administration (USFDA) to market tizanidine hydrochloride capsules, USP in strengths of 2mg, 4mg and 6mg," Zydus Cadila said in a regulatory filing today. Money Control, 3 weeks ago
[x]  

19 images for zydus cadila

Money Control, 3 weeks ago
Money Control, 1 month ago
Business Standard India, 2 months ago
Money Control, 2 months ago
Franchise India, 2 months ago
Moneycontrol.com, 3 months ago
DealStreetAsia, 3 months ago
India Infoline, 2 months ago
DealStreetAsia, 2 months ago
Odisha Television, 2 months ago
Sify

Cadila Health up 3% on product launch USFDA nod to skin drug

Cadila’s subsidiary, Zydus Cadila, received regulatory approvals to launch tetravalent inactivated influenza vaccine for seasonal flu in India. Meanwhile, Zydus received the approval from US Food and Drug Administration (FDA) for Linezolid tablets. These ...
 Money Control1 month ago Cadila Healthcare gets Form 483 from USFDA; Stock recovers after sharp setback  Sify4 weeks ago Zydus Cadila to launch influenza fighting vaccine in India  Business Standard1 month ago Zydus Cadila to launch seasonal flu vaccine in India  DNA1 month ago
Money Control

Zydus acquires Sentnyl, a US specialty pharma company

A leading global healthcare company, Zydus Cadila on January 19, announced that ithas acquired Sentnyl Therapeutics Inc., which is a US based specialty in the pharmaceutical business.
 India Infoline2 months ago Zydus Cadila acquires Sentynl Therapeutics Inc  Money Control2 months ago Zydus Cadila acquires US-based Sentynl Therapeutics  Business Standard2 months ago Zydus Cadila open for buyouts in the US  Business Standard2 months ago
[x]  
Money Control

Cadila's subsidiary settles its patent litigation

Zydus Pharmaceuticals (USA) Inc., a subsidiary of Cadila Healthcare Limited, which is a global pharmaceuticals company, has today announced that they have finalised an agreement with Upsher-Smith Laboratories Inc., to settle the patent litigation with ...
 India Infoline2 months ago Cadila settles patent litigation related to Livalo tablets  Business Standard2 months ago
[x]  

Zydus settles case with Upsher-Smith on Qudexy

Pharmaceuticals company Cadila Healthcare and its subsidiary Zydus Pharmaceuticals (US) have finalised an agreement with Upsher-Smith Laboratories, a regulatory filing said here on Friday.This would settle all outstanding patent litigation related to Qudexy ...
 Prokerala2 months ago
Money Control

Cadila inks pact with Supernus Pharma to settle patent issue

Cadila Healthcare today said that it has finalised a pact with Supernus Pharmaceuticals to settle patent litigation regarding Trokendi XR extended-release capsules, used for treatment of seizures. Cadila Healthcare, along with subsidiary Zydus Pharmaceuticals ...
 Business Standard3 weeks ago Need to keep pace with industry on tech upgradation: Sun Pharma  Money Control1 month ago

Sensex Remains Range Bound; Metal Stocks Drag

Posted by Equitymaster After opening the day strong, share markets in India witnessed selling and are trading marginally above the dotted line. Sectoral indices are trading on a mixed note with stocks in the consumer durables and telecom sector leading the ...
 Equitymaster.com2 weeks ago Sensex Finishes Marginally Lower; Banking Stocks Drag  Equitymaster.com1 month ago Global Markets Continues to be Volatile  Equitymaster.com2 months ago Sensex Finishes Marginally Lower; TCS Gains 0.9%  Equitymaster.com2 months ago

Sensex, Nifty caught in tight band amid stock specific activity

The market is quite sluggish today with investors largely treading cautiously, looking ahead to the US President Donald Trump's speech on Tuesday, which is likely to spell out some elements of his plans to cut taxes. Activity is quite stock specific with ...
 Sify1 month ago
Sify

Sensex hits 29,000 mark; TCS, Infosys among top gainers

Thanks to sustained buying in telecom, information technology and a few front line stocks from capital goods and consumer durables sectors, the market holds in positive territory this afternoon. The Sensex moved past the 29,000 mark this afternoon, hitting ...
 Sify1 month ago
Rediff.com

Why Japan is betting big on Indian pharma cos

One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions, report Sohini Das & Aneesh Phadnis. Japan's Bank of Tokyo-Mitsubishi UFJ (BTMU), part of the Mitsubishi UFJ Financial Group (MUFG), is taking aggressive bets in Indian pharmaceuticals. Pharma is its second largest segment in Indian loan exposure, after oil and gas. The group would not disclose the total of India ...
 Rediff.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less